Related by context. All words. (Click for frequent words.) 72 novel peptide 70 G Protein Coupled 70 therapeutic monoclonal antibodies 70 anticancer therapeutics 69 small molecule inhibitors 69 molecular biomarkers 68 FGFR 68 antisense inhibitors 67 histone deacetylase HDAC 67 investigational humanized monoclonal antibody 67 ETBs 67 Protein Kinase C 67 Receptors GPCRs 67 small molecule activators 67 monoclonal antibody mAb 67 HepDirect prodrug 67 mitotic kinesin 67 small molecule agonists 67 Anticalins R 67 neuronal nicotinic receptors NNRs 67 humanized monoclonal 67 peptidomimetic 66 Fc fusion protein 66 taxane derivative 66 highly selective inhibitor 66 selective inhibition 66 splice variants 66 therapeutic monoclonal antibody 66 preclinically 66 Factor VIIa 66 Fibroblast Growth Factor Receptor 65 peptibody 65 MTP inhibitor 65 targeting CD# 65 potent inhibitors 65 PKC isoforms 65 antisense inhibitor 65 MDRNA proprietary 65 JAK2 inhibitor 65 adrenergic regulation 65 novel peptides 65 isoform selective 65 activin receptor type 65 Locked Nucleic Acid 65 BCR ABL inhibitors 65 VEGF receptor 65 NPC 1C 65 mGluR4 65 M2 subunit 65 TLR9 agonist 65 intracellular protein 65 humanized monoclonal antibody 65 serine protease 65 HCV polymerase 65 Blinatumomab 65 USP# 65 PI3 K 64 serine threonine kinase 64 RNA antagonist 64 cellular pathways 64 Squalamine 64 prolyl 64 Pathway Inhibitor 64 PI3 kinase 64 selective antagonists 64 MEK inhibitors 64 TLR9 agonists 64 HCV NS3 protease 64 A3 adenosine receptor 64 DNA intercalator 64 humanized monoclonal antibodies 64 NTDDS 64 mitogen activated ERK kinase 64 FLT3 64 GMX# 64 depsipeptide 64 selectively inhibited 64 phosphatidylinositol 3 64 CCR1 64 targeted antifolate 64 phosphate S1P 64 RAF kinase 64 selective inhibitors 64 SAR# [002] 64 Enzastaurin 64 Alfacell proprietary ribonuclease 64 histone methyltransferases HMTs 64 intracellular signaling pathways 64 selective androgen receptor modulators 64 HDACs 64 TLR8 64 predictive biomarkers 64 peroxisome proliferator activated 64 PI3K/mTOR 64 potently inhibit 64 hypoxia inducible factor 64 SinuNase ™ 64 Wnt signaling pathway 64 JAK kinases 64 PDGF receptor 64 histone deacetylase inhibitors 64 MEK inhibitor 64 GPCR targets 64 HCV protease 64 mTOR mammalian target 63 prodrugs 63 siRNA therapeutic 63 cyclic peptide 63 theranostic 63 Cathepsin S 63 PDE4 inhibitor 63 chemokine receptor 63 Nanobody 63 PDE# inhibitors 63 RNAi therapeutic targeting 63 SGLT2 63 Anticalins ® 63 cyclin dependent kinase inhibitor 63 HER1 63 myeloproliferative disorders 63 diagnostic biomarkers 63 polymerase inhibitors 63 DiLA2 63 orally bioavailable 63 histone deacetylase inhibitor 63 THR beta agonist 63 cyclin dependent kinases 63 AT1R 63 cathepsins 63 shRNA libraries 63 epigenetic enzymes 63 IAP inhibitor 63 kinase PI3K 63 histone deacetylase 63 protein tyrosine phosphatase 1B 63 Nanobody ® 63 factor receptor FGFR 63 sodium glucose cotransporter 63 cell adhesion molecule 63 NS5b 63 mda 7 63 Janus kinase 63 orally administered inhibitor 63 rxRNA 63 Calando proprietary 63 bioactive lipids 63 CCR9 63 PI3K Akt 63 oral Janus kinase 63 kinesin spindle protein 63 IIB ActRIIB 63 ENMD # 63 myelin repair 63 antiproliferative activity 63 BiTE ® 63 clinically validated targets 63 bispecific 63 apoptotic pathway 63 novel antiviral therapeutics 63 matrix metalloproteases 63 glucagon receptor 63 engineered proteases 63 Janus Kinase 63 HCV protease inhibitors 63 JAK inhibitors 63 chemically modified siRNA 63 Smac mimetics 62 Kinase Inhibitor 62 thyroid hormone receptor 62 histone acetyltransferase 62 Phylomer ® 62 inhibit viral replication 62 5 HT4 receptor 62 antitumoral 62 antifibrotic 62 small molecule defensin 62 prolyl hydroxylase inhibitors 62 mutational status 62 epothilones 62 Factor Receptor 62 SGLT2 inhibitors 62 P#X# 62 antisense oligonucleotide 62 protein tyrosine phosphatases 62 RNA antagonists 62 synthetic siRNA 62 siRNA therapeutics 62 HSP# inhibitor 62 Epidermal Growth Factor Receptor 62 aberrantly activated 62 PI3K inhibitor 62 proprietary LNA 62 selective immunoproteasome inhibitor 62 Factor VEGF 62 3 kinase PI3K 62 Vaccinex 62 poly ADP ribose polymerase 62 HTRF 62 SIRT2 62 IGF 1R 62 novel antibody therapeutics 62 Vegenics 62 Histone 62 biologic therapeutics 62 anti secretory 62 anionic backbone 62 immune modulation 62 developing TB4 62 pharmacodynamic biomarkers 62 novel therapeutic antibodies 62 monoclonal antibody MAb 62 adenosine A2A 62 CB1 antagonists 62 CCR3 62 mTOR kinase 62 anticancer therapies 62 cytoprotective 62 proteasome inhibitor 62 kinase pathway 62 Liposomal 62 Locked Nucleic Acid LNA 62 ligases 62 cholesteryl ester transfer 62 p# mitogen activated 62 small molecule thrombopoietin 62 resolvins 62 immunotherapeutics 62 tumor antigens 62 NS5A 62 Affimed Therapeutics AG 62 CB2 receptor 62 myeloproliferative diseases 62 cell signaling pathways 62 selective kinase inhibitor 62 ubiquitin ligases 62 Elvitegravir 62 small molecule inhibitor 62 PPARγ 62 antimitotic 62 multi kinase inhibitor 62 deacetylase 62 nitric oxide donating 62 vitro assay 62 ErbB3 62 histone deacetylases 62 proteasome inhibitors 62 peptide antigens 62 LNP formulations 62 ribonuclease 62 PTP 1B 62 single stranded oligonucleotides 62 mertansine 62 Gamma secretase 62 AVI NEUGENE 62 Cytotoxic T 62 novel immunomodulatory 62 non nucleoside HCV 62 peptide hormone 62 Notch receptors 62 anticancer compounds 62 humanized antibody 62 protein kinases 62 outlicensed 62 cathepsin K inhibitor 62 5 HT2A serotonin 62 peptide ligands 62 Cisbio Bioassays 62 5 HT6 62 ankyrin repeat 62 engineered RAP peptides 62 kinase inhibition 62 2 inhibitor CYT# 62 poly ethylene glycol PEG 62 metabolite identification 62 tubulin inhibitor 62 Clusterin 62 tumor antigen 61 JAK1 61 antibody MT# 61 XL# XL# 61 GPR# agonist 61 mGluR2 NAM 61 c KIT 61 biased ligand 61 benzimidazole 61 cytokine receptor 61 Carfilzomib 61 NS#/#A protease 61 novel orally administered 61 romazarit 61 metabolite profiling 61 myelofibrosis polycythemia vera 61 Amira Pharmaceuticals 61 receptor PPAR 61 potently inhibits 61 neurokinin 1 61 protein mTOR 61 investigational therapies 61 FGFR3 61 liposomal delivery 61 coupled receptor GPCR 61 Adnectin 61 vascular disrupting agents 61 c MET 61 antibody MAb 61 tyrosine kinase inhibitor 61 synthetic retinoid 61 virosome 61 telomerase inhibitors 61 ArQule Kinase Inhibitor Platform 61 Monoclonal antibody 61 subtype selective 61 SGLT Inhibitors 61 small molecule chemotherapeutic 61 pharmacodynamic markers 61 small molecule glucokinase 61 E#F# 61 HDACi 61 CENP E 61 receptor tyrosine kinase inhibitor 61 telomerase inhibitor 61 CCR2 61 naturally occurring molecule 61 microRNA miRNA 61 activate SIRT1 61 prostaglandin D2 61 AtuRNAi 61 histone deacetylase HDAC inhibitors 61 commercialize microRNA 61 HepDirect R 61 coupled receptors GPCRs 61 B lymphocyte stimulator 61 monocytes macrophages 61 GSK3B 61 acetylcholinesterase AChE 61 ALK inhibitors 61 triphosphate 61 metabotropic glutamate receptors 61 tranilast 61 cellular signaling pathways 61 Preclinical studies suggest 61 chemokine 61 SMARTICLES ® 61 serine threonine 61 CDKs 61 Kinases 61 DNA methylation biomarkers 61 androgen receptor AR 61 peptidic 61 drug conjugates ADCs 61 novel anticancer 61 ZFP TFs 61 peptide therapeutics 61 GPR# agonists 61 immunoregulatory 61 partial agonist 61 drug conjugates 61 Aptamer 61 Angiolix 61 selective modulator 61 coactivator 61 sphingosine kinase 61 enhance ApoA 61 proto oncogene 61 TNF receptors 61 therapeutic peptide 61 Topoisomerase 61 maytansinoid 61 antisense drug 61 effector function 61 pathophysiological effects 61 potent topoisomerase II 61 adipogenic 61 gastro intestinal inflammation 61 acadesine 61 UsiRNAs 61 IAP inhibitors 61 NF kB pathway 61 Hypoxia Inducible Factor 61 lysophosphatidic acid LPA 61 rapamycin mTOR 61 NEUGENE R 61 JAK3 61 Pertuzumab 61 kinase enzymes 61 prostanoid 61 lipopeptide 61 inverse agonist 61 agonist compounds 61 selective antagonist 61 novel anti infective 61 selectively inhibiting 61 Guanilib 61 beta secretase inhibitors 61 cyclin dependent kinase CDK 61 multicenter Phase II 61 Curaxin CBLC# 61 potent antiproliferative 61 enzymatic pathways 61 tubulin binding 61 chimeric monoclonal antibody 61 Ataluren 61 nicotinic acetylcholine receptor 61 EGFR HER 61 targeting PCSK9 61 NNRs 61 secretory phospholipase A2 61 secreted protein 61 chemokine receptors 61 fosbretabulin 61 Protein Kinase 61 RECOTHROM R 61 Trophos 61 monoclonal antibody therapeutics 61 POTELLIGENT ® 61 Deforolimus 61 protein tyrosine kinase 61 OMP #M# 61 NuMimetic TM 61 Anticalin R 61 retinoic acid receptor 61 SARMs 61 Anti angiogenic 61 Pentad TM 61 PPARgamma 61 Cathepsin B 61 epothilone 61 CDK inhibitor 61 enzyme inhibitors 61 c myb 60 affinity ligands 60 ANGPTL4 60 recombinant protein 60 peripherally acting 60 thymosin beta 4 60 epigenetic therapeutics 60 AEG# 60 RON Notch 60 biobetter 60 proapoptotic 60 IgG1 antibody 60 HepDirect 60 HSP# inhibitors 60 targeted anticancer therapies 60 IGF IR 60 VitiGam 60 siRNA binds 60 MAbs targeting 60 anti CD3 60 highly selective endothelin 60 selectively inhibit 60 DNA methyltransferases 60 inactivating mutations 60 biologic pathways 60 allosteric modulation 60 mRNA sequences 60 Tissue Factor 60 delipidation 60 dasatinib Sprycel 60 5 HT4 60 NSCLC tumors 60 PROfusion 60 recombinant polyclonal antibodies 60 detection reagents 60 mitogen activated protein kinase 60 mitotic kinesins 60 novel VDA molecule 60 recombinant antibodies 60 phosphoprotein 60 proprietary polysaccharide 60 CEQ# 60 immunoregulation 60 interferon lambda 60 FGFR1 60 non nucleoside 60 selectively inhibits 60 IgG1 monoclonal antibody 60 agonists antagonists 60 targeted radiotherapeutic 60 optical biosensors 60 Homspera TM 60 peptide receptor 60 metalloprotease 60 PDE4 60 glucokinase 60 drug metabolizing enzymes 60 polyketides 60 c Raf kinase 60 maturation inhibitors 60 NovaBay Aganocide compounds 60 mGlu2 3 60 thrombin receptor 60 JAK#/JAK# 60 humanized anti 60 siRNA sequences 60 kidney urologic 60 synthetic peptide 60 Archexin 60 selective inhibitor 60 FOLOTYN ® 60 co stimulatory molecules 60 DGAT 60 ImQuest 60 tiapamil 60 LEAD Therapeutics 60 Sphingomab 60 Scil Proteins 60 antisense drugs 60 ActRIIB 60 Hsp# inhibitors 60 folate receptor 60 Flt3 60 Stapled Peptide 60 Activating mutations 60 herpes simplex viruses 60 biocatalytic processes 60 kinase inhibitor 60 Tibotec BVBA 60 metabotropic glutamate receptor 60 small molecule activator 60 MEK ERK 60 GelSite R polymer 60 familial amyloidotic polyneuropathy FAP 60 Pentraxin 2 60 Chemokine Receptor 60 Spiegelmer 60 Aurora kinases 60 novel kinase inhibitors 60 tRNA synthetase 60 ghrelin antagonist 60 oral ghrelin agonist 60 biomarker assays 60 ribonucleotide reductase clinically validated 60 Onconase 60 tyrosine kinase receptor 60 Aurora kinase 60 recombinant fibrinogen 60 Affibody ® molecules 60 microtubule inhibitor 60 SGLT 60 Poly ICLC 60 potently inhibited 60 tumor microenvironment 60 Aurora kinase inhibitor 60 phosphatases 60 HER pathway 60 receptor CXCR4 60 protein kinase inhibitor 60 Tyrima 60 antibody fragment therapeutics 60 novel immunotherapies 60 TRAIL receptor 60 ALN TTR 60 TGR5 60 biomarker identification 60 CD# monoclonal antibody 60 vivo validation 60 glucocorticoid receptor 60 pharmacogenetic test 60 Systemic Delivery 60 TGF alpha 60 immune stimulatory 60 beta 1a 60 ddRNAi 60 Eg5 60 P#X# antagonist 60 potent inhibitor 60 biased ligands 60 Olaparib 60 Receptos 60 short hairpin RNAs 60 thymidylate synthase TS 60 reversible inhibitor 60 multikinase inhibitor 60 Cytochrome P# 60 signaling cascades 60 isoform selective inhibitors 60 vanilloid receptor 60 humanised antibody 60 HER2 HER3 60 NMDA N 60 Corgentin 60 oral prodrug 60 fatty acid biosynthesis 60 PI3 Kinase 60 selective estrogen receptor modulator 60 Teplizumab 60 Creabilis Therapeutics 60 opioid receptor antagonist 60 commercializing anti infective 60 anticancer agents 60 biologic pathway 60 generation antisense 60 Personalized Immunotherapy 60 epigenetic therapies 60 immune modulator 60 Tß4 60 TÎ ² 4 60 polycythemia vera PV 60 cationic lipid 60 sphingosine 1 60 immune modulatory 60 Nedd4 60 AMPK activators 60 Kosan dependence 60 lipid nanoparticle 60 Capsulution 60 accumulate preferentially 60 AKT inhibitor 60 MorphoSys proprietary 60 immatics 59 ligand TRAIL 59 Notch receptor 59 cyclins 59 vascular disrupting agent 59 SGLT inhibitors 59 adult mesenchymal stem 59 signal transduction pathways 59 oral antiviral 59 Ube Industries Ltd. 59 Anticalins 59 selective agonist 59 non nucleoside inhibitor 59 Bafetinib 59 SMIP 59 methylated DNA 59 fast skeletal troponin 59 CoVal TM fusion 59 PKM2 59 Cylene 59 KineMarker TM 59 TLR antagonists 59 cytostatic 59 modified nucleoside 59 receptors PPARs 59 fusion proteins 59 druggable targets 59 anti fibrotic 59 Aviptadil 59 vemurafenib 59 JAK inhibitor 59 specific lectin receptors 59 histone deacetylases HDACs 59 intercellular signaling 59 elbion 59 Tarvacin TM 59 polymerase inhibitor 59 MAPK 59 human antibody therapeutics 59 Reverse Cholesterol Transport 59 homodimers 59 vesicular monoamine transporter 59 neuroprotective properties 59 GABAB receptors 59 liposomal formulation 59 MolecularBreeding 59 uPAR 59 Novosom 59 IGF1R 59 Abl 59 delta isoform 59 TGF Beta 59 melanocortin receptors 59 Curaxins 59 nicotinic alpha 7 59 hedgehog pathway 59 small molecule 59 PPARg 59 phosphoinositide 3 59 receptor subtypes 59 MET VEGFR2 59 Viprovex TM 59 staphylococcal vaccine 59 molecularly targeted 59 TLR Therapeutics 59 geldanamycin 59 candidate deforolimus 59 antiviral compounds 59 intracellular signaling 59 carbohydrate polymer 59 HDAC enzymes 59 cMET 59 CK2 59 tumorigenicity 59 microRNA molecules 59 anticoagulant reversing agent 59 antagomirs 59 adenoviral 59 Annexin A5 59 receptor tyrosine kinase 59 p# subunit 59 genomic biomarkers 59 sodium glucose transporter 59 coronary vasodilation 59 ATL# [002] 59 Wnt beta catenin 59 amino acid peptide 59 Hsp# inhibition 59 MCSP respectively 59 NS4A 59 lipid nanoparticles 59 Cx# [002] 59 mutational analysis 59 Monoclonal antibodies 59 Tumor Necrosis Factor 59 serine proteases 59 signal transduction inhibitors 59 oxazolidinone 59 ErbB1 59 receptor modulators 59 Panzem NCD 59 peptide conjugated 59 ProtAffin 59 miRNA biomarkers 59 VEGF inhibitors 59 Pancreate 59 BiTE R 59 Pink Sheets RHHBY 59 lymphotoxin 59 telomerase reverse transcriptase 59 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 59 AKIP ™ 59 HuLuc# 59 inhibit angiogenesis 59 Upregulation 59 nucleoside analog 59 alpha#beta# integrin 59 phosphoinositide 59 reverse vaccinology 59 enzymology 59 ATL# [001] 59 platform HDL Mimetic 59 transient receptor 59 Anticalin ® 59 RAS RAF MEK 59 Glycosylation 59 druggable target 59 Tarvacin Anti Viral 59 SPL# Gel vaginal microbicide 59 personalized dendritic 59 VEGF receptors 59 Kiadis 59 Topoisomerase II 59 Oncogenic 59 miRNA therapeutics 59 GGTase 59 erlotinib Tarceva ® 59 EGFR pathway 59 HDAC inhibition 59 synthetic peptides 59 dopamine D2 59 RAF kinase VEGFR 59 Nicotinic 59 peroxisomal 59 pan HDAC inhibitor 59 AKT1 59 Angiotensin Converting Enzyme 59 EGFR HER2 59 ABLYNX 59 Granulocyte Colony Stimulating Factor 59 Fc fusion proteins 59 Nasdaq CGEN 59 small molecule Hedgehog 59 Anidulafungin 59 inhibit KSP 59 cancer immunotherapies 59 pro angiogenic 59 HGS# 59 Methylnaltrexone 59 GPR# [002] 59 Immunotherapeutic 59 prostaglandin synthesis 59 immunotoxin 59 IL# PE#QQR 59 Trandolapril 59 angiogenesis inhibitor 59 Virdante 59 calcitonin gene related 59 thrombopoietin 59 apoptosis proteins 59 optimal dosing regimens 59 thromboxane A2 59 IgG1 59 molecular chaperone 59 purinergic receptors P#X# 59 p# MAPK 59 Aplidin 59 Marqibo TM 59 mediated inhibition 59 potent cytotoxic 59 ADAMTS# 59 GW# [003] 59 Aromatase 59 antiapoptotic 59 enzyme inhibitor 59 Curaxin 59 Galenea 59 PKC# 59 GIPET 59 immune modulating 59 LHRH antagonists 59 Aurora Kinase 59 1α 59 extracellular signal 59 CDK inhibitors 59 non coding RNA 59 glucokinase activator 59 HIF 1alpha 59 NS4B 59 biochemical assays 59 Cdc7 59 MAP kinase 59 SERMs 59 ProNAi 59 reverse transcriptase inhibitors 59 Interferons 59 Genfit 59 AAG geldanamycin analog 59 A2A receptor 59 CRAC channel 59 aurora kinase 59 cellular immunotherapy 59 albumin binding 59 Talabostat 59 synthases 59 genomic biomarker 59 HQK 59 Cyto Pulse 59 PSN# [002] 59 isotypes 59 ARRY # 59 DiLA2 Platform 59 ERK1 2 59 DPX Survivac 59 transcriptional regulation 59 radionuclide therapy 59 5 HT2A receptor 59 Solazed TM 59 Fleximer 59 ADP receptor antagonist 59 Trastuzumab DM1 59 beta lactamases 59 E2F 59 biochemical profiling 59 NEUGENE antisense 59 CXCR7 59 HuCAL antibody 59 sd rxRNA 59 BRAF kinase 59 tumor hypoxia 59 penetrating peptides 59 stable nucleic acid 59 Cethrin R 59 validating biomarkers 59 tests miRview TM 59 DNA plasmids 59 cortisol receptor 59 pDCs 59 mimetics 59 5 HT2B receptor 59 p# inhibitor 59 galectin 59 hedgehog signaling pathway 59 SCD1 59 Spiegelmers R 59 tumor suppressor protein 59 eIF 4E 59 tyrosine kinase 59 preclinical efficacy 59 antibody reagents 59 anaplastic lymphoma kinase ALK 59 Synthase 59 CCR5 mAb 59 Vidofludimus 59 substrate specificity 59 lipid mediators 59 γ secretase 59 molecular determinants 59 metalloenzymes 59 tubulin inhibitors 59 adenosine receptor 58 Sym# 58 metabolic enzymes 58 pharmacological chaperones 58 chimeric antibody 58 membrane receptors 58 hERG 58 PIK3CA 58 methyltransferase 58 recombinant fusion 58 lipopeptides 58 Rho GTPases 58 Spiegelmer ® 58 inhibitor RG# 58 Nereus Pharmaceuticals 58 receptor partial agonist 58 EHT AGN 58 glycolipids 58 orally bioavailable mimics 58 novel immunotherapeutic 58 Enkephalin 58 RECOTHROM ® 58 Epidermal Growth Factor 58 gene loci 58 diarrhea predominant irritable 58 Kinase 58 receptor alpha 58 leukotriene pathway 58 fusion enhancers 58 TLE3 58 extracellular matrices 58 antisense oligonucleotides 58 VEGFR2 58 oncolytic viruses 58 theranostics 58 NF KB 58 microRNA biomarkers 58 biocatalysts 58 HER3 58 Delta opioid receptor 58 beta amyloid peptide 58 exon skipping 58 Bucindolol 58 cardiac myosin 58 EGF receptor 58 Transfersome ® 58 peptide fragment 58 protein kinase C 58 lymphangiogenesis 58 siRNAs targeting 58 Biodesix 58 CYT# novel 58 eotaxin 58 C5aR 58 Viprovex R 58 anti angiogenic drugs 58 NKT Therapeutics 58 hormone gastrin 58 Etubics 58 Silodosin 58 POTELLIGENT R 58 Ridaforolimus 58 BAY #-# 58 #beta HSD1 58 biosynthetic pathways 58 STK# [002] 58 Presents Preclinical Data 58 radezolid 58 focal adhesion kinase FAK 58 PSN# [001] 58 dAbs 58 endogenous ligands 58 Epothilones 58 HCV replication 58 mesenchymal cell 58 Tumor necrosis factor 58 guanosine 58 Supernus Pharmaceuticals 58 Fibroblast 58 Hsp# Inhibitor 58 keratinocyte 58 HepDirect technology 58 florbetaben 58 LSD1 58 peroxidase 58 allosteric 58 potent inhibition 58 Nanobodies 58 immunological diseases 58 ZFN 58 KSP inhibitor 58 CB2 selective 58 Small Molecule 58 nitric oxide donating prostaglandin 58 siRNA mediated 58 humanized antibodies 58 HIF 1α 58 ZFP Therapeutics 58 proprietary PEGylation 58 cyclophilin inhibitor 58 regulated kinase 58 annexin 58 BiTE 58 Taligen Therapeutics 58 topoisomerase II inhibitor 58 TRAIL induced apoptosis 58 YONDELIS 58 HCV NS5B polymerase 58 ZK EPO 58 Antisense 58 neurite outgrowth 58 PLK1 58 immunotherapeutic approaches 58 BMS # 58 Euroscreen 58 Myolimus 58 rxRNA ™ compounds 58 immunomodulator 58 Symadex